abagovomab 35
abciximab 31
abituzumab 22
abrilumab 19
actoxumab 18
adalimumab 21
aducanumab 15
afasevikumab 20
alacizumab_pegol 13
alemtuzumab 24
alirocumab 22
amatuximab 42
andecaliximab 24
anifrolumab 22
anrukinzumab 23
aprutumab 18
aprutumab_ixadotin 18
arcitumomab 25
ascrinvacumab 7
atezolizumab 16
atinumab 16
avelumab 14
basiliximab 32
bavituximab 39
begelomab 28
benralizumab 28
bevacizumab_beta 24
bezlotoxumab 18
bimagrumab 15
bleselumab 15
blinatumomab 36
blosozumab 29
bococizumab 19
brazikumab 18
brentuximab_vedotin 35
briakinumab 20
brodalumab 13
brolucizumab 28
brontictuzumab 27
burosumab 18
cabiralizumab 26
camrelizumab 16
canakinumab 27
cantuzumab_ravtansin 47
carlumab 15
carotuximab 30
cergutuzumab_amunaleukin2 27
cergutuzumab_amunaleukin 27
certolizumab_pegol 25
cetiximab 47
citatuzumab_bogatox 27
cixutumumab 27
clivatuzumab_tetraxetan 24
codrituzumab 31
conatumumab 13
concizumab 33
crenezumab 21
crizanlizumab 26
crotedumab 21
dacetuzumab 22
daclizumab 13
dalotuzumab 39
dapirolizumab_pegol 26
daratumumab 14
dectrekumab 11
demcizumab 26
denosumab 10
depatuxizumab 23
depatuxizumab_mafodotin 23
dezamizumab 21
dinutuximab 39
diridavumab 30
domagrozumab 18
drozitumab 18
duligotuzumab 21
durvalumab 11
dusigitumab 19
efalizumab 33
efungumab 30
eldelumab 17
elezanumab 22
elgemtumab 13
elotuzumab 18
emactuzumab 19
emapalumab 25
emibetuzumab 19
enavatuzumab 25
enfortumab_vedotin 14
enoblituzumab 20
enokizumab 25
enoticumab 20
ensituximab 34
eptinezumab 19
erenumab 22
etaracizumab 18
etrolizumab 22
evinacumab 22
evolocumab 17
farletuzumab 14
fasinumab 23
fezakinumab 23
fibatuzumab 14
ficlatuzumab 21
firivumab 34
flanvotumab 19
fletikumab 25
foralumab 15
foravirumab 16
fremanezumab 31
fresolimumab 17
fulranumab 22
futuximab 32
galcanezumab 21
ganitumab 26
gantenerumab 13
gemetuzumab 28
gemtuzumab2 26
gemtuzumab 27
gevokizumab 24
girentuximab 31
glembatumumab 17
glembatumumab_vedotin 17
guselkumab 24
ibalizumab 27
ibritumomab 36
icrucumab 13
idarucizumab 37
ifabotuzumab 14
imalumab 19
imgatuzumab 20
inclacumab 21
indatuximab_ravtansin 37
indusatumab 18
inebilizumab 30
intetumumab 17
iodine_girentuximab 30
ipilimumab 7
iratumumab 14
isatuximab 39
itolizumab 27
ixekizumab 32
labetuzumab_govitecan 21
lambrolizumab 29
lampalizumab 24
lanadelumab 18
landogrozumab 18
laprituximab 28
lebrikizumab 35
lendalizumab 23
lenzilumab 16
lifastuzumab_vedotin 25
ligelizumab 25
lilotomab 39
lirilumab 24
lodelcizumab 16
lokivetmab 27
lorvotuzumab_mertansin 28
lucatumumab 30
lumretuzumab 19
lupartumab 16
lutikizumab 21
margetuximab 37
milatuzumab 42
mirvetuximab 38
mirvetuximab_soravtansin 38
modotuximab 43
mogamulizumab 36
monalizumab 17
motavizumab 34
moxetumomab_pasudotox 33
namilumab 20
naratuximab 29
naratuximab_emtansin 29
narnatumab 20
navicixizumab2 29
navicixizumab 27
navivumab 39
necitumumab 12
nemolizumab 25
nesvacumab 17
nivolumab 13
obiltoxaximab 21
obinutuzumab 36
ocaratuzumab 27
ofatumumab 20
olaratumab 19
olokizumab 25
omalizumab 20
onartuzumab 23
ontuxizumab 23
opicinumab 14
orticumab 16
otelixizumab 39
oxelumab 13
ozanezumab 33
pamrevlumab 13
panobacumab 30
parsatuzumab 25
pasotuxizumab 23
pateclizumab 19
patritumab 20
pembrolizumab 29
perakizumab 23
pidilizumab 20
pinatuzumab_vedotin 19
plozalizumab 33
pogalizumab 23
polatuzumab_vedotin 22
ponezumab 38
prezalumab 16
pritoxaximab 39
quilizumab 23
racotumomab 33
radretumab 15
ralpancizumab 22
ramucirumab 14
ranevetmab 28
ranibizumab 24
refanezumab 25
remtolumab 20
rilotumumab 20
rinucumab 19
risankizumab 34
rituximab 24
rivabazumab 22
robatumumab 20
roledumab 35
romosozumab 20
rontalizumab 19
rosmantuzumab 25
rozanolixizumab 23
sacituzumab 30
sacituzumab_govitecan 30
samalizumab 26
sapelizumab 23
sarilumab 18
secukinumab 16
seribantumab 17
setoxaximab 46
sifalimumab 10
siltuximab 25
simtuzumab 28
sirukumab 13
solanezumab 27
solitomab 29
stamulumab 17
suptavumab 25
suvizumab 22
tabalumab 12
tadocizumab 19
tamtuvetmab 32
tanezumab 22
tarextumab 12
tavolixizumab 18
telisotuzumab 26
teplizumab 21
tesidolumab 23
tezepelumab 26
tigatuzumab 17
tildrakizumab 22
timolumab 16
tisotumab 16
tosatoxumab 39
tositumomab 33
tralokinumab 26
trastuzumab 24
tregalizumab 25
trevogrumab 14
ublituximab 29
urelumab 20
ustekinumab 29
utomilumab 27
vadastuximab 25
vadastuximab_talirin 25
vandortuzumab_vedotin 17
vantictumab 22
vanucizumab2 24
vanucizumab 28
varlilumab 17
vatelizumab 21
vedolizumab 31
veltuzumab 16
vesencumab 12
vorsetuzumab 23
vorsetuzumab_mafodotin 23
vunakizumab 36
xentuzumab 20
zatuximab 43
